Nasal high-flow bronchodilator nebulization: a randomized cross-over study - Centre d’Etude des Pathologies Respiratoires (CEPR), UMR 1100
Article Dans Une Revue Annals of Intensive Care Année : 2018

Nasal high-flow bronchodilator nebulization: a randomized cross-over study

Résumé

Background: There is an absence of controlled clinical data showing bronchodilation effectiveness after nebulization via nasal high-flow therapy circuits. Results: Twenty-five patients with reversible airflow obstruction received, in a randomized order: (1) 2.5 mg albuterol delivered via a jet nebulizer with a facial mask; (2) 2.5 mg albuterol delivered via a vibrating mesh nebulizer placed downstream of a nasal high-flow humidification chamber (30 L/min and 37 °C); and (3) nasal high-flow therapy without nebulization. All three conditions induced significant individual increases in forced expiratory volume in one second (FEV1) compared to baseline. The median change was similar after facial mask nebulization [+ 350 mL (+ 180; + 550); + 18% (+ 8; + 30)] and nasal high flow with nebulization [+ 330 mL (+ 140; + 390); + 16% (+ 5; + 24)], p = 0.11. However, it was significantly lower after nasal high-flow therapy without nebulization [+ 50 mL (− 10; + 220); + 3% (− 1; + 8)], p = 0.0009. FEV1 increases after facial mask and nasal high-flow nebulization as well as residual volume decreases were well correlated (p < 0.0001 and p = 0.01). Both techniques showed good agreement in terms of airflow obstruction reversibility (kappa 0.60). Conclusion: Albuterol vibrating mesh nebulization within a nasal high-flow circuit induces similar bronchodilation to standard facial mask jet nebulization. Beyond pharmacological bronchodilation, nasal high flow by itself may induce small but significant bronchodilation.
Fichier principal
Vignette du fichier
2018_12_21_AirVoNeb-Annals_of_Intensive_Care.pdf (844.33 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-02527399 , version 1 (01-04-2020)

Licence

Identifiants

Citer

François Reminiac, Laurent Vecellio, Laëtitia Bodet-Contentin, Valerie Gissot, Deborah Le Pennec, et al.. Nasal high-flow bronchodilator nebulization: a randomized cross-over study. Annals of Intensive Care, 2018, 8, pp.128. ⟨10.1186/s13613-018-0473-8⟩. ⟨hal-02527399⟩
103 Consultations
175 Téléchargements

Altmetric

Partager

More